Screening for microRNA-based diagnostic markers in hepatic alveolar echinococcosis.


Journal

Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R

Informations de publication

Date de publication:
Sep 2019
Historique:
entrez: 14 9 2019
pubmed: 14 9 2019
medline: 1 10 2019
Statut: ppublish

Résumé

This study aims to screen differentially expressed host miRNAs that could be used as diagnostic markers for liver alveolar echinococcosis (LAE).Differentially expressed miRNAs were first screened by miRNA microarray in liver tissues from2 LAE patients and normal liver tissues from 3 LAE patients, followed by qRT-PCR validation in 15 LAE tissues and 15 normal tissues. Target genes of differentially expressed miRNAs were predicted using Targetscan, PITA and microRNAorg database, and the overlapped predicted target genes were analyzed by GO and KEGG.The hsa-miR-1237-3p, hsa-miR-33b-3p, and hsa-miR-483-3p were up-regulated whereas the hsa-miR-4306 was down-regulated in LAE tissues compared with normal controls (P < .05). The expression change of miR-483-3p was further confirmed in both liver tissues and plasma. Several predicted targets of miR-1237-3p, miR-4306, and miR-483-3p were related to DNA-dependent transcriptional regulation, developmental regulation of multicellular organisms, and biological functions such as cellular immune responses (T cell proliferation). The overlapped predicted target genes of the 4 differentially expressed miRNAs were enriched in mRNA surveillance, cancer signaling pathway, intestinal immune network, and other signal pathways.Our results indicate that miR-483-3p is a potential marker for the diagnosis of LAE, and targets of this miRNA could be the focus of further studies.

Identifiants

pubmed: 31517861
doi: 10.1097/MD.0000000000017156
pii: 00005792-201909130-00052
pmc: PMC6750324
doi:

Substances chimiques

Biomarkers 0
MicroRNAs 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e17156

Références

Ann Neurol. 2013 Jun;73(6):729-40
pubmed: 23494648
Clin Epigenetics. 2017 Dec 12;9:127
pubmed: 29255496
Int J Mol Sci. 2016 Jan 09;17(1):
pubmed: 26761003
Postgrad Med J. 2003 Feb;79(928):113-4
pubmed: 12612332
Cell Res. 2008 Oct;18(10):983-4
pubmed: 18833286
J Parkinsons Dis. 2012;2(4):321-31
pubmed: 23938262
Malar J. 2017 Aug 15;16(1):334
pubmed: 28807026
Parasit Vectors. 2014 Nov 20;7:522
pubmed: 25409540
Parasitology. 2013 Nov;140(13):1685-92
pubmed: 23985352
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1990;8(1):38-40
pubmed: 2364503
Acta Trop. 2017 Feb;166:39-44
pubmed: 27810427
Diabetes. 2019 Feb;68(2):349-360
pubmed: 30257976
J Hepatol. 2013 Feb;58(2):234-9
pubmed: 23085648
Cell Death Dis. 2017 Sep 7;8(9):e3045
pubmed: 28880270
Braz J Med Biol Res. 2018 Oct 18;51(12):e7574
pubmed: 30365725
FASEB J. 2011 Sep;25(9):3092-105
pubmed: 21676945
Parasit Vectors. 2013 May 29;6:154
pubmed: 23718711
Parasitol Int. 2010 Jun;59(2):283-5
pubmed: 20193774
Blood. 2013 Jun 20;121(25):4977-84
pubmed: 23550041
RNA Biol. 2013 Mar;10(3):371-9
pubmed: 23392243
Eur Spine J. 2015 Aug;24(8):1738-46
pubmed: 25850393
Parasit Vectors. 2013 Sep 20;6:272
pubmed: 24330517
Int J Med Sci. 2016 Feb 18;13(3):195-205
pubmed: 26941580
Parasitology. 2017 Jul;144(8):1079-1087
pubmed: 28270244
Biochem Biophys Res Commun. 2016 Sep 2;477(4):541-547
pubmed: 27346130
Parasitology. 2013 Dec;140(14):1751-61
pubmed: 23942009
Exp Mol Pathol. 2015 Oct;99(2):253-61
pubmed: 26148929
Mol Biochem Parasitol. 2012 Dec;186(2):81-6
pubmed: 23069113
Pathol Res Pract. 2018 Oct;214(10):1556-1563
pubmed: 30082158
Theranostics. 2013 Nov 29;3(12):930-42
pubmed: 24396504
Nat Rev Endocrinol. 2013 Sep;9(9):513-21
pubmed: 23629540
Nucleic Acids Res. 2005 Mar 01;33(4):1290-7
pubmed: 15741182
Parasite Immunol. 1999 Aug;21(8):409-21
pubmed: 10417675
Oncotarget. 2016 May 24;7(21):31361-71
pubmed: 27120784
Transl Res. 2019 Mar;205:77-91
pubmed: 30391474
Clin Cancer Res. 2019 Mar 1;25(5):1505-1516
pubmed: 30171046
Cancer Biol Med. 2013 Sep;10(3):123-30
pubmed: 24379986
Cancers (Basel). 2018 Jun 04;10(6):
pubmed: 29867024
PLoS One. 2017 Jan 24;12(1):e0169626
pubmed: 28118363
Mol Cancer. 2010 Nov 26;9:306
pubmed: 21110877
Hepatology. 1997 May;25(5):1090-5
pubmed: 9141422
PLoS Negl Trop Dis. 2014 Feb 20;8(2):e2701
pubmed: 24587461
Front Immunol. 2018 Aug 06;9:1761
pubmed: 30131802
Front Genet. 2013 Nov 12;4:214
pubmed: 24273550
Front Cell Infect Microbiol. 2016 Feb 02;6:5
pubmed: 26870701
Int J Oncol. 2015 Feb;46(2):539-47
pubmed: 25384963
Hepatology. 1996 Jan;23(1):57-61
pubmed: 8550049

Auteurs

Bin Ren (B)

Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an.
Department of Hepatopancreatobiliary Surgery, Affiliated Hospital of Qinghai University, Xining, China.

Haijiu Wang (H)

Department of Hepatopancreatobiliary Surgery, Affiliated Hospital of Qinghai University, Xining, China.

Li Ren (L)

Department of Hepatopancreatobiliary Surgery, Affiliated Hospital of Qinghai University, Xining, China.

Cairang Yangdan (C)

Department of Hepatopancreatobiliary Surgery, Affiliated Hospital of Qinghai University, Xining, China.

Ying Zhou (Y)

Department of Hepatopancreatobiliary Surgery, Affiliated Hospital of Qinghai University, Xining, China.

Haining Fan (H)

Department of Hepatopancreatobiliary Surgery, Affiliated Hospital of Qinghai University, Xining, China.

Yi Lv (Y)

Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH